We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.83%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Valero Energy
VLO
$87.1B
| $86.3M | 0.2% |
505,308
-198,473
| -28% | -$28.4M |
|
127
MetLife
MET
$61.9B
| $85.1M | 0.2% |
1,147,678
-876,259
| -43% | -$61.1M |
|
128
CAVA Group
CAVA
$7.71B
| $84.5M | 0.2% |
1,206,372
+1,188,408
| +6,615% | +$63.7M |
|
129
Coca-Cola
KO
$374B
| $84.2M | 0.2% |
1,375,618
+1,065,779
| +344% | +$64M |
|
130
MSCI
MSCI
$41.6B
| $82.5M | 0.19% |
147,129
+30,064
| +26% | +$16.9M |
|
131
Verisk Analytics
VRSK
$24.6B
| $82.4M | 0.19% |
349,399
+340,846
| +3,985% | +$81.9M |
|
132
Intel
INTC
$510B
| $82.3M | 0.19% |
1,863,525
+1,345,269
| +260% | +$59.9M |
|
133
Snowflake
SNOW
$110B
| $82.3M | 0.19% |
509,344
-705,939
| -58% | -$137M |
|
134
Fortinet
FTNT
$120B
| $81.9M | 0.19% |
1,199,124
-2,193,481
| -65% | -$146M |
|
|
135
Merck
MRK
$317B
| $80.7M | 0.19% |
611,403
-1,616,116
| -73% | -$199M |
|
136
PUT
Norwegian Cruise Line
NCLH
$9.32B
| $79.5M | 0.19% |
3,796,000
-1,629,800
| -30% | -$29.6M |
|
137
Bank of Montreal
BMO
$127B
| $78.5M | 0.18% |
803,140
-43,800
| -5% | -$4.14M |
|
138
Hilton Worldwide
HLT
$73B
| $78.3M | 0.18% |
367,263
+189,550
| +107% | +$37.3M |
|
139
Ecolab
ECL
$80.3B
| $78.2M | 0.18% |
338,465
-71,959
| -18% | -$15.3M |
|
140
SLB Ltd
SLB
$74.1B
| $77.8M | 0.18% |
1,420,184
-1,956,945
| -58% | -$98.7M |
|
141
Palantir
PLTR
$380B
| $76.5M | 0.18% |
3,325,925
+3,216,525
| +2,940% | +$68.5M |
|
142
PUT
Royal Caribbean
RCL
$87.6B
| $76.5M | 0.18% |
550,000
-724,900
| -57% | -$90.5M |
|
143
ARK Innovation ETF
ARKK
$6.05B
| $76.3M | 0.18% |
1,523,400
-590,640
| -28% | -$28.8M |
|
144
Cboe Global Markets
CBOE
$29.7B
| $76.2M | 0.18% |
414,796
+108,978
| +36% | +$20.1M |
|
145
Atlassian
TEAM
$28.8B
| $76.1M | 0.18% |
389,994
+287,739
| +281% | +$62.7M |
|
146
Estee Lauder
EL
$31.5B
| $75.9M | 0.18% |
492,337
-666,757
| -58% | -$94.6M |
|
147
PVH
PVH
$4.01B
| $75.2M | 0.18% |
534,901
+514,201
| +2,484% | +$65.8M |
|
148
SolarEdge
SEDG
$2.06B
| $75.2M | 0.18% |
1,059,244
-94,784
| -8% | -$6.84M |
|
149
DuPont de Nemours
DD
$19.9B
| $74.5M | 0.17% |
773,703
+224,341
| +41% | +$20M |
|
150
CleanSpark
CLSK
$3.46B
| $73.5M | 0.17% |
3,466,603
+1,207,448
| +53% | +$16.8M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.